Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01070121 · ClinicalTrials.gov registry record

Treatment Efficacy and Toxicity in Rheumatoid Arthritis Database and Repository

A clinical trial of Rheumatoid Arthritis, sponsored by University of Alabama at Birmingham.

Completed
Registry status
200
Enrollment target
9
Study locations

NCT01070121 is a study of Rheumatoid Arthritis that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 200 participants, below the 4,690-participant average among 197 other Rheumatoid Arthritis trials with a reported enrollment target (96% lower). The trial reports 9 study locations across 9 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01070121, a study of Rheumatoid Arthritis, has completed, sponsored by University of Alabama at Birmingham.

COMPLETED
Registry status
200 participants
Enrollment target
9
Study locations

Study Summary

To stimulate collaborative efforts of federal funding agencies, voluntary health agencies, professional organizations and industry partners to enable creation of a large, sustainable database and repository to better understand the molecular basis of treatment and rapidly accelerate translational research in RA.

Conditions Studied

Study Locations (9)

Alabama

  • University of Alabama at Birmingham - Birmingham

California

  • Stanford University - Palo Alto

Colorado

  • University of Colorado in Denver - Aurora

Maryland

  • Johns Hopkins University - Baltimore

Massachusetts

  • Brigham and Women's Hospital - Boston

Nebraska

  • University of Nebraska Medical Center - Omaha

New York

  • North Shore Medical Center (LIJ Health System) - Lake Success

North Carolina

  • Duke University - Durham

Trial Details

FieldValue
Enrollment Target 200 participants
Start Date 2010-02
Est. Completion 2012-08

Sponsor

University of Alabama at Birmingham

1,160 total trials

What the Registry Record Tells You About NCT01070121

The ClinicalTrials.gov registry entry for NCT01070121 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,690-participant average among 197 other Rheumatoid Arthritis trials with a reported enrollment target (96% lower). The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Rheumatoid Arthritis appearing as the primary indexed condition, and to 0 interventions.

NCT01070121 reports 9 study locations spanning 9 distinct geographic areas - top geographies include Alabama, California, Colorado.

Frequently Asked Questions

What is clinical trial NCT01070121 about?

NCT01070121 is a clinical study titled "Treatment Efficacy and Toxicity in Rheumatoid Arthritis Database and Repository". To stimulate collaborative efforts of federal funding agencies, voluntary health agencies, professional organizations and industry partners to enable creation of a large, sustainable database and repository to better understand the molecular basis of treatment and rapidly accelerate translational re...

What is the current status of trial NCT01070121?

This trial is currently completed. The enrollment target is 200 participants. The study started on 2010-02. Estimated completion is 2012-08.

What conditions does trial NCT01070121 study?

This clinical trial studies the following conditions: Rheumatoid Arthritis.

Who is sponsoring clinical trial NCT01070121?

This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01070121 being conducted?

This trial has 9 study locations across Alabama, California, Colorado, Maryland, Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Rheumatoid Arthritis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.